TMDX PEER ANALYSIS

TransMedics Group Inc — metric-by-metric comparison with peers and the industry median

TMDXTransMedics Group Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

TMDXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	TMDX	4DX	COH	PHIA	SN	SHL	Ind. Median
P/E	14.50●	—	23.72	24.65	20.56	18.77	27.44
P/B	5.05	-74.16●	4.23	2.10	2.48	2.16	2.48
EV/EBITDA	20.71	—	14.87	10.82	9.88●	11.97	15.23
P/S	3.92	243.16	3.47	1.36●	2.09	1.70	2.66

Financial Health
Metric	TMDX	4DX	COH	PHIA	SN	SHL	Ind. Median
Current Ratio	6.74●	6.57	2.46	1.32	2.57	1.10	3.28
Debt/Equity	174.8%	-22.6%●	22.1%	71.1%	62.9%	84.1%	44.7%
NetDebt/EBITDA	2.87	0.71	0.42●	2.03	1.72	3.04	0.82

Profitability
Metric	TMDX	4DX	COH	PHIA	SN	SHL	Ind. Median
Net Margin	27.0%●	-3,684.6%	14.6%	5.5%	10.1%	9.1%	-5.7%
ROE	45.2%●	—	18.1%	8.4%	12.1%	11.4%	-8.6%
ROA	15.1%●	-264.3%	12.4%	3.6%	6.1%	4.6%	-6.4%
EBITDA Margin	22.0%	-818.8%	24.0%	15.4%	25.6%●	19.1%	5.2%

Growth + Dividend
Metric	TMDX	4DX	COH	PHIA	SN	SHL	Ind. Median
Rev. Growth	30.2%●	-26.0%	2.0%	-1.9%	—	-0.3%	7.4%
NI Growth	251.2%●	—	-6.8%	160.1%	—	0.3%	16.7%
Div. Yield	—	—	3.6%●	3.5%	3.5%	2.9%	1.1%
Payout	—	—	81.5%	33.8%	52.8%	48.4%	39.0%

Valuation
Metric	TMDX	AXGN	UFPT	NEOG	BFLY	NVCR	Ind. Median
P/E	14.50●	—	30.95	—	—	—	27.44
P/B	5.05	9.67	4.84	0.97●	10.30	5.94	2.48
EV/EBITDA	20.71	—	19.44●	—	—	—	15.23
P/S	3.92	9.94	3.49	2.34●	19.14	2.91	2.66

Financial Health
Metric	TMDX	AXGN	UFPT	NEOG	BFLY	NVCR	Ind. Median
Current Ratio	6.74	7.10●	2.91	3.92	4.02	2.90	3.28
Debt/Equity	174.8%	8.4%●	35.6%	37.7%	10.3%	71.0%	44.7%
NetDebt/EBITDA	2.87	7.53	1.17	-1.41●	1.77	1.33	0.82

Profitability
Metric	TMDX	AXGN	UFPT	NEOG	BFLY	NVCR	Ind. Median
Net Margin	27.0%●	-13.2%	11.3%	-69.9%	-73.6%	-25.7%	-5.7%
ROE	45.2%●	-18.0%	17.2%	-25.6%	-35.2%	-50.0%	-8.6%
ROA	15.1%●	-13.0%	10.4%	-16.5%	-25.1%	-17.0%	-6.4%
EBITDA Margin	22.0%●	-3.5%	19.1%	-51.5%	-64.8%	-23.0%	5.2%

Growth + Dividend
Metric	TMDX	AXGN	UFPT	NEOG	BFLY	NVCR	Ind. Median
Rev. Growth	30.2%●	22.4%	11.2%	-3.9%	20.2%	8.5%	7.4%
NI Growth	251.2%●	—	8.1%	—	—	—	16.7%
Div. Yield	—	—	—	—	—	—	1.1%
Payout	—	—	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on TMDX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.